Oncology

Gastroenteropancreatic Neuroendocrine Tumors

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2023 NANETS Multidisciplinary NET Medical Symposium

conference reporter by Jennifer R. Eads, MD; Thorvadur R. Halfdanarson, MD

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Gastroenteropancreatic Neuroendocrine Tumors presented at this year’s 2023 NANETS Multidisciplinary NET Medical Symposium.

VIEW THE TOPICS

Advancing Neuroendocrine Tumor Research: Resources and Strategies
Gastroenteropancreatic Neuroendocrine Tumors and the Current Treatment Landscape
Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials in Progress and Future Directions
Interdisciplinary Perspectives and Joint Symposia on Neuroendocrine Tumors
Personalizing Therapy for Patients With Gastroenteropancreatic Neuroendocrine Tumors

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the North American Neuroendocrine Tumor Society.

Profile

Jennifer R. Eads, MD

Associate Professor of Clinical Medicine
Physician Lead, GI Clinical Research
Director, National Clinical Trials Network
Director, Penn Neuroendocrine Tumor Program
Division of Hematology and Oncology
University of Pennsylvania, Abramson Cancer Center
Perelman Center for Advanced Medicine
Philadelphia, PA